Citation Impact
Citing Papers
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Mechanism of All-trans-retinal Toxicity with Implications for Stargardt Disease and Age-related Macular Degeneration
2011
Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats
2004
Sex Differences in the HPA Axis
2014
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
2006
Natural products: An evolving role in future drug discovery
2011 Standout
Diversity of actions of GnRHs mediated by ligand-induced selective signaling
2007
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
2004
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Psychedelics
2016 Standout
Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicity
2007
Impact of COVID-19 pandemic on mental health in the general population: A systematic review
2020 Standout
Biological roles of glycans
2016 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Polysaccharides from Wolfberry Antagonizes Glutamate Excitotoxicity in Rat Cortical Neurons
2009
The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis
2009
Alzheimer's disease
2006 Standout
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
The stress system in the human brain in depression and neurodegeneration
2005
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target
2013 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Natural products to drugs: natural product derived compounds in clinical trials
2005
The interpersonal theory of suicide.
2010 Standout
Agonist-Induced Serotonin 2A Receptor Desensitization in the Rat Frontal Cortex and Hypothalamus
2004
Brain serotonin system in the coordination of food intake and body weight
2010
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Natural products in drug discovery
2008 Standout
Chemistry and Function of Glycosaminoglycans in the Nervous System
2014
Sustained treatment with a 5-HT2A receptor agonist causes functional desensitization and reductions in agonist-labeled 5-HT2A receptors despite increases in receptor protein levels in rats
2008
The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
2014
Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease
2004
Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects
2008
Heparin - A Century of Progress
2012
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
2014
Involvement of Neurokinin Receptors in the Control of Pulsatile Luteinizing Hormone Secretion in Rats
2011
Natural product and natural product derived drugs in clinical trials
2014 Standout
Dynamics of gonadotropin-releasing hormone release during a pulse.
1992 Standout
A review of botanical characteristics, phytochemistry, clinical relevance in efficacy and safety of Lycium barbarum fruit (Goji)
2011 Standout
The Traditional Medicine and Modern Medicine from Natural Products
2016 Standout
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Works of Bertalan Dudás being referenced
Topography and Associations of Leu-Enkephalin and Luteinizing Hormone-Releasing Hormone Neuronal Systems in the Human Diencephalon
2003
The blood–brain barrier accessibility of a heparin-derived oligosaccharides C3
2002
Glycosaminoglycans and Neuroprotection
2011
Bi-directional associations between galanin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon
2004
Close Juxtapositions between LHRH Immunoreactive Neurons and Substance P Immunoreactive Axons in the Human Diencephalon
2002
Protection against inflammatory neurodegeneration and glial cell death by 7β-hydroxy epiandrosterone, a novel neurosteroid
2004
Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain
2002
Three‐Dimensional Representation of the Neurotransmitter Systems of the Human Hypothalamus: Inputs of the Gonadotrophin Hormone‐Releasing Hormone Neuronal System
2005
Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo
2004
Close Juxtapositions between LHRH Immunoreactive Neurons and Substance P Immunoreactive Axons in the Human Diencephalon
2002
Evidence That 5-HT2AReceptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (−)DOI
2002